Effects of a Post-Shock Injection of the Kappa Opioid Receptor Antagonist Norbinaltorphimine (norBNI) on Fear and Anxiety in Rats

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Rogala, Benjamin ^a   Li, Yonghui ^b   Li, Sa ^a   Chen, Xiaoyu ^a   Kirouac, Gilbert J ^a,c  

^a UNIVERSITY OF MANITOBA   (Canada)

^b INSTITUTE OF PSYCHOLOGY   (China)

^c UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

KAPPA OPIATE RECEPTOR; NORBINALTORPHIMINE;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; AVOIDANCE BEHAVIOR; CONTROLLED STUDY; DEFENSIVE BEHAVIOR; DOSE RESPONSE; DRUG MEGADOSE; FEAR; FOOTSHOCK; LATENT PERIOD; MALE; NONHUMAN; RAT; TRANQUILIZING ACTIVITY;

ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; FEAR; INJECTIONS, SUBCUTANEOUS; MALE; NALTREXONE; RATS; RECEPTORS, OPIOID, KAPPA;

RATTUS;

EID: 84869131576     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049669     Document Type: Article

References (67)

1. Charney DS, Deutch AY, Krystal JH, Southwick SM, Davis M, (1993) Psychobiologic mechanisms of posttraumatic stress disorder. Arch Gen Psychiatry 50: 295-305.
2. Stam R, (2007) PTSD and stress sensitisation: a tale of brain and body Part 1: human studies. Neurosci Biobehav Rev 31: 530-557.
3. Bonne O, Grillon C, Vythilingam M, Neumeister A, Charney DS, (2004) Adaptive and maladaptive psychobiological responses to severe psychological stress: implications for the discovery of novel pharmacotherapy. Neurosci Biobehav Rev 28: 65-94.
4. North CS, Suris AM, Davis M, Smith RP, (2009) Toward validation of the diagnosis of posttraumatic stress disorder. Am J Psychiatry 166: 34-41.
5. Berger W, Mendlowicz MV, Marques-Portella C, Kinrys G, Fontenelle LF, et al. (2009) Pharmacologic alternatives to antidepressants in posttraumatic stress disorder: a systematic review. Prog Neuropsychopharmacol Biol Psychiatry 33: 169-180.
6. Steckler T, Risbrough V, (2011) Pharmacological treatment of PTSD- Established and new approaches. Neuropharmacology.
7. Siegmund A, Wotjak CT, (2007) A mouse model of posttraumatic stress disorder that distinguishes between conditioned and sensitised fear. J Psychiatr Res 41: 848-860.
8. Mikics E, Baranyi J, Haller J, (2008) Rats exposed to traumatic stress bury unfamiliar objects-a novel measure of hyper-vigilance in PTSD models? Physiol Behav 94: 341-348.
9. Louvart H, Maccari S, Lesage J, Leonhardt M, Dickes-Coopman A, et al. (2006) Effects of a single footshock followed by situational reminders on HPA axis and behaviour in the aversive context in male and female rats. Psychoneuroendocrinology 31: 92-99.
10. Louvart H, Maccari S, Ducrocq F, Thomas P, Darnaudery M, (2005) Long-term behavioural alterations in female rats after a single intense footshock followed by situational reminders. Psychoneuroendocrinology 30: 316-324.
11. van Dijken HH, Mos J, van der Heyden JA, Tilders FJ, (1992) Characterization of stress-induced long-term behavioural changes in rats: evidence in favor of anxiety. Physiol Behav 52: 945-951.
12. Van Dijken HH, Tilders FJ, Olivier B, Mos J, (1992) Effects of anxiolytic and antidepressant drugs on long-lasting behavioural deficits resulting from one short stress experience in male rats. Psychopharmacology (Berl) 109: 395-402.
13. Daviu N, Fuentes S, Nadal R, Armario A, (2010) A single footshock causes long-lasting hypoactivity in unknown environments that is dependent on the development of contextual fear conditioning. Neurobiol Learn Mem 94: 183-190.
14. Chen X, Li Y, Li S, Kirouac GJ, (2012) Early fear as a predictor of avoidance in a rat model of post-traumatic stress disorder. Behav Brain Res 226: 112-117.
15. Mikics E, Toth M, Varju P, Gereben B, Liposits Z, et al. (2008) Lasting changes in social behavior and amygdala function following traumatic experience induced by a single series of foot-shocks. Psychoneuroendocrinology 33: 1198-1210.
16. Bruijnzeel AW, Stam R, Wiegant VM, (2001) Effect of a benzodiazepine receptor agonist and corticotropin-releasing hormone receptor antagonists on long-term foot-shock-induced increase in defensive withdrawal behavior. Psychopharmacology (Berl) 158: 132-139.
17. Bruijnzeel AW, Stam R, Wiegant VM, (2001) LY354740 attenuates the expression of long-term behavioral sensitization induced by a single session of foot shocks. Eur J Pharmacol 426: 77-80.
18. Pamplona FA, Henes K, Micale V, Mauch CP, Takahashi RN, et al. (2011) Prolonged fear incubation leads to generalized avoidance behavior in mice. J Psychiatr Res 45: 354-360.
19. Chavkin C, James IF, Goldstein A, (1982) Dynorphin is a specific endogenous ligand of the kappa opioid receptor. Science 215: 413-415.
20. Schwarzer C, (2009) 30 years of dynorphins-new insights on their functions in neuropsychiatric diseases. Pharmacol Ther 123: 353-370.
21. Knoll AT, Carlezon WA Jr, (2010) Dynorphin, stress, and depression. Brain Res 1314: 56-73.
22. Nestler EJ, Carlezon WA Jr, (2006) The mesolimbic dopamine reward circuit in depression. Biol Psychiatry 59: 1151-1159.
23. Carlezon WA Jr, Beguin C, Knoll AT, Cohen BM, (2009) Kappa-opioid ligands in the study and treatment of mood disorders. Pharmacol Ther 123: 334-343.
24. Pfeiffer A, Brantl V, Herz A, Emrich HM, (1986) Psychotomimesis mediated by kappa opiate receptors. Science 233: 774-776.
25. Bals-Kubik R, Ableitner A, Herz A, Shippenberg TS, (1993) Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats. J Pharmacol Exp Ther 264: 489-495.
26. Mague SD, Pliakas AM, Todtenkopf MS, Tomasiewicz HC, Zhang Y, et al. (2003) Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats. J Pharmacol Exp Ther 305: 323-330.
27. Carlezon WA Jr, Beguin C, DiNieri JA, Baumann MH, Richards MR, et al. (2006) Depressive-like effects of the kappa-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats. J Pharmacol Exp Ther 316: 440-447.
28. Ebner SR, Roitman MF, Potter DN, Rachlin AB, Chartoff EH, (2010) Depressive-like effects of the kappa opioid receptor agonist salvinorin A are associated with decreased phasic dopamine release in the nucleus accumbens. Psychopharmacology (Berl) 210: 241-252.
29. Knoll AT, Meloni EG, Thomas JB, Carroll FI, Carlezon WA Jr, (2007) Anxiolytic-like effects of kappa-opioid receptor antagonists in models of unlearned and learned fear in rats. J Pharmacol Exp Ther 323: 838-845.
30. Carr GV, Lucki I, (2010) Comparison of the kappa-opioid receptor antagonist DIPPA in tests of anxiety-like behavior between Wistar Kyoto and Sprague Dawley rats. Psychopharmacology (Berl) 210: 295-302.
31. Wittmann W, Schunk E, Rosskothen I, Gaburro S, Singewald N, et al. (2009) Prodynorphin-derived peptides are critical modulators of anxiety and regulate neurochemistry and corticosterone. Neuropsychopharmacology 34: 775-785.
32. Shirayama Y, Ishida H, Iwata M, Hazama GI, Kawahara R, et al. (2004) Stress increases dynorphin immunoreactivity in limbic brain regions and dynorphin antagonism produces antidepressant-like effects. J Neurochem 90: 1258-1268.
33. Peters MF, Zacco A, Gordon J, Maciag CM, Litwin LC, et al. (2011) Identification of short-acting kappa-opioid receptor antagonists with anxiolytic-like activity. Eur J Pharmacol 661: 27-34.
34. McLaughlin JP, Li S, Valdez J, Chavkin TA, Chavkin C, (2006) Social defeat stress-induced behavioral responses are mediated by the endogenous kappa opioid system. Neuropsychopharmacology 31: 1241-1248.
35. McLaughlin JP, Marton-Popovici M, Chavkin C, (2003) Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses. J Neurosci 23: 5674-5683.
36. Land BB, Bruchas MR, Lemos JC, Xu M, Melief EJ, et al. (2008) The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system. J Neurosci 28: 407-414.
37. Carr GV, Bangasser DA, Bethea T, Young M, Valentino RJ, et al. (2010) Antidepressant-like effects of kappa-opioid receptor antagonists in wistar kyoto rats. Neuropsychopharmacology 35: 752-763.
38. Fanselow MS, Kim JJ, Young SL, Calcagnetti DJ, DeCola JP, et al. (1991) Differential effects of selective opioid peptide antagonists on the acquisition of pavlovian fear conditioning. Peptides 12: 1033-1037.
39. Endoh T, Matsuura H, Tanaka C, Nagase H, (1992) Nor-binaltorphimine: a potent and selective kappa-opioid receptor antagonist with long-lasting activity in vivo. Arch Int Pharmacodyn Ther 316: 30-42.
40. Jones DN, Holtzman SG, (1992) Long term kappa-opioid receptor blockade following nor-binaltorphimine. Eur J Pharmacol 215: 345-348.
41. Blanchard RJ, Blanchard DC, (1969) Passive and active reactions to fear-eliciting stimuli. J Comp Physiol Psychol 68: 129-135.
42. Spanagel R, Almeida OF, Shippenberg TS, (1993) Long lasting changes in morphine-induced mesolimbic dopamine release after chronic morphine exposure. Synapse 14: 243-245.
43. Takahashi LK, Kalin NH, Vanden Burgt JA, Sherman JE, (1989) Corticotropin-releasing factor modulates defensive-withdrawal and exploratory behavior in rats. Behav Neurosci 103: 648-654.
44. Gutman DA, Owens MJ, Skelton KH, Thrivikraman KV, Nemeroff CB, (2003) The corticotropin-releasing factor1 receptor antagonist R121919 attenuates the behavioral and endocrine responses to stress. J Pharmacol Exp Ther 304: 874-880.
45. White DA, Kalinichev M, Holtzman SG, (2007) Locomotor response to novelty as a predictor of reactivity to aversive stimuli in the rat. Brain Res 1149: 141-148.
46. Stam R, (2007) PTSD and stress sensitisation: a tale of brain and body Part 2: animal models. Neurosci Biobehav Rev 31: 558-584.
47. Cole S, Richardson R, McNally GP, (2011) Kappa opioid receptors mediate where fear is expressed following extinction training. Learn Mem 18: 88-95.
48. Kamprath K, Wotjak CT, (2004) Nonassociative learning processes determine expression and extinction of conditioned fear in mice. Learn Mem 11: 770-786.
49. Roman E, Arborelius L, (2009) Male but not female Wistar rats show increased anxiety-like behaviour in response to bright light in the defensive withdrawal test. Behav Brain Res 202: 303-307.
50. Li Y, Li S, Wei C, Wang H, Sui N, et al. (2010) Orexins in the paraventricular nucleus of the thalamus mediate anxiety-like responses in rats. Psychopharmacology (Berl) 212: 251-265.
51. Davis M, (1998) Are different parts of the extended amygdala involved in fear versus anxiety? Biol Psychiatry 44: 1239-1247.
52. Davis M, Shi C, (1999) The extended amygdala: are the central nucleus of the amygdala and the bed nucleus of the stria terminalis differentially involved in fear versus anxiety? Ann N Y Acad Sci 877: 281-291.
53. Davis M, Walker DL, Miles L, Grillon C, (2010) Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety. Neuropsychopharmacology 35: 105-135.
54. Carobrez AP, Bertoglio LJ, (2005) Ethological and temporal analyses of anxiety-like behavior: the elevated plus-maze model 20 years on. Neurosci Biobehav Rev 29: 1193-1205.
55. Ohl F, Toschi N, Wigger A, Henniger MS, Landgraf R, (2001) Dimensions of emotionality in a rat model of innate anxiety. Behav Neurosci 115: 429-436.
56. Rodgers RJ, (1997) Animal models of 'anxiety': where next? Behav Pharmacol 8: 477-496; discussion 497-504.
57. Rosen JB, Schulkin J, (1998) From normal fear to pathological anxiety. Psychol Rev 105: 325-350.
58. McLaughlin J, See RE, (2003) Selective inactivation of the dorsomedial prefrontal cortex and the basolateral amygdala attenuates conditioned-cued reinstatement of extinguished cocaine-seeking behavior in rats. Psychopharmacology (Berl) 168: 57-65.
59. Zhang H, Shi YG, Woods JH, Watson SJ, Ko MC, (2007) Central kappa-opioid receptor-mediated antidepressant-like effects of nor-Binaltorphimine: behavioral and BDNF mRNA expression studies. Eur J Pharmacol 570: 89-96.
60. Schank JR, Goldstein AL, Rowe KE, King CE, Marusich JA, et al. (2012) The kappa opioid receptor antagonist JDTic attenuates alcohol seeking and withdrawal anxiety. Addict Biol 17: 634-647.
61. Berrendero F, Maldonado R, (2002) Involvement of the opioid system in the anxiolytic-like effects induced by Delta(9)-tetrahydrocannabinol. Psychopharmacology (Berl) 163: 111-117.
62. Saitoh A, Hirose N, Yamada M, Nozaki C, Oka T, et al. (2006) Changes in emotional behavior of mice in the hole-board test after olfactory bulbectomy. J Pharmacol Sci 102: 377-386.
63. Perrine SA, Hoshaw BA, Unterwald EM, (2006) Delta opioid receptor ligands modulate anxiety-like behaviors in the rat. Br J Pharmacol 147: 864-872.
64. Rodgers RJ, Augar R, Berryman N, Hansom CJ, OMahony ML, et al. (2006) Atypical anxiolytic-like response to naloxone in benzodiazepine-resistant 129S2/SvHsd mice: role of opioid receptor subtypes. Psychopharmacology (Berl) 187: 345-355.
65. Yehuda R, (2002) Post-traumatic stress disorder. N Engl J Med 346: 108-114.
66. Bisson JI, (2007) Post-traumatic stress disorder. Bmj 334: 789-793.
67. Shalev AY, (2009) Posttraumatic stress disorder and stress-related disorders. Psychiatr Clin North Am 32: 687-704.